RecruitingNCT06896344

Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells

Studying Primary myelofibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Principal Investigator
Margherita Massa, PhD
IRCCS Policlinico San Matteo Foundation
Intervention
In vitro culture(other)
Enrollment
10 target
Eligibility
18 years · All sexes
Timeline
2024 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06896344 on ClinicalTrials.gov

Other trials for Primary myelofibrosis

Additional recruiting or active studies for the same condition.

See all trials for Primary myelofibrosis →

← Back to all trials